Works matching IS 25785745 AND DT 2019 AND VI 1 AND IP 2
Results: 9
Issue Information.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 2, p. 71, doi. 10.1002/acr2.1028
- Publication type:
- Article
Baseline Description of the Juvenile Localized Scleroderma Subgroup From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 2, p. 119, doi. 10.1002/acr2.1019
- By:
- Publication type:
- Article
Differences in Longitudinal Disease Activity Between Research Cohort and Noncohort Participants with Rheumatoid Arthritis Using Electronic Health Record Data.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 2, p. 113, doi. 10.1002/acr2.1017
- By:
- Publication type:
- Article
Pregnancy, Periods, and "The Pill": Exploring the Reproductive Experiences of Women with Inflammatory Arthritis.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 2, p. 125, doi. 10.1002/acr2.1016
- By:
- Publication type:
- Article
Body‐Self Unity With a New Hip or Knee: Understanding Total Joint Replacement Within an Embodiment Framework.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 2, p. 90, doi. 10.1002/acr2.1014
- By:
- Publication type:
- Article
Association between Pre‐intervention Physical Activity Level and Treatment Response to Exercise Therapy in Persons with Knee Osteoarthritis—An Exploratory Study.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 2, p. 104, doi. 10.1002/acr2.1013
- By:
- Publication type:
- Article
The Self‐Administered Rheumatoid Arthritis Disease Activity Index (RADAI) is Less Accurate than DAS28‐CRP as a Disease Activity Measure in Pregnancy.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 2, p. 97, doi. 10.1002/acr2.1012
- By:
- Publication type:
- Article
Interferon Chemokine Score and Other Cytokine Measures Track With Changes in Disease Activity in Patients With Juvenile and Adult Dermatomyositis.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 2, p. 83, doi. 10.1002/acr2.1011
- By:
- Publication type:
- Article
Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open‐Label, Long‐Term Extension Studies up to 9.5 Years.
- Published in:
- ACR Open Rheumatology, 2019, v. 1, n. 2, p. 73, doi. 10.1002/acr2.1010
- By:
- Publication type:
- Article